“ Our research within AI does not stop. We have new systems that can generate biological data indistinguishable from real biological data and can now imagine high-quality… ”
In Conversation
“ Fundamentally, we need to keep an open mind about learning from existing models, yet should avoid simply copying and pasting what has worked in other countries… ”
“ My personal mission is to position Pangenia to be one of the largest molecular diagnostics companies based in Hong Kong, facing the South East Asian market ”
“ JLABS @ Shanghai is a no-strings-attached incubator, which means entrepreneurs are free to develop their science while holding on to their intellectual property - providing a… ”
“ Looking at the longer term, I believe this COVID-19 crisis will have a positive impact on the diagnostics industry by changing the approach countries take towards… ”
“ Given our status as a raw materials developer, we see an opportunity to expand our offering during this pandemic. Our agility and ability to re-orientate our… ”
“ Hong Kong has a unique profile, with both Chinese and international DNA. From a markets point of view, we have demonstrated that our markets are robust… ”
“ Oncolytic virus is not necessarily a competitor of standard therapies that are already present in the market such as CAR-T or checkpoint inhibitors. Oncolytic virus works… ”
“ The core business – our research-driven, data-driven approach to innovation – has not changed [post-IPO]. We are committed to developing our portfolio and generating value for… ”
“ The silver lining of the crisis is that it has provided opportunities for small companies to work together and perhaps grow together ”
“ Before the IPO, we might have been seen as a mostly Chinese company working on interesting science and products, but now we are evidently a globally-ready… ”
“ From the time of Harbour BioMed’s inception in 2016, we have always set out to be a patient-centric global biotech company with multiple forms of value… ”
